Top insights from the latest market news from Monday, April 20, from The Motley Fool analysts on Team Rule Breakers and Team ...

Did you know that it has been more than seven years since Canada legalized marijuana for recreational use? At the time, there ...

This beverage innovator, known for its coconut water brands, reported a notable insider sale amid strong annual share price ...

Eli Lilly has another promising drug in its portfolio with Foundayo. Its growth rate has been more than 40% in recent ...

American Electric Power and NextEra Energy are two utilities poised to benefit from surging electricity demand.

Compass Pathways has already reported two positive phase 3 trials for treatment-resistant depression (TRD). The company's ...

The stock trades at close to 80 times its trailing earnings, but that is likely to improve as it grows its profits. When ...

This international dividend stock ETF has recently outperformed the ProShares S&P 500 Dividend Aristocrats® ETF.

You don't need to find the next 100x growth stock to build serious wealth. Sometimes, the real opportunity lies in owning ...

Cerebras originally planned its initial public offering (IPO) last year but shelved its plans after raising $1 billion in ...

Tesla (TSLA 1.34%) stock is down 18% from its peak, and the company is wrestling with an assortment of headwinds. Tariffs on ...

Ian Cleminson reported, As we move into 2025, the one thing that is going to be slightly different for us is that in 2024, we ...